FZO is a 'long duration' play as it's still not profitable and not generating positive cash flow, and is only expected to do so a fair way into the future. As such what we're seeing in the bond markets with higher long-term risk-free rates is going to disproportionately impact a long duration company like FZO. That being said, a close to 20% reduction in price over the last little while is IMO an overreaction.
Way I view FZO is that it's like a snowball: Extremely sticky revenue base that keeps increasing yoy - so just need to be patient with this until it hits the break-even point. I haven't done my own analysis on this break-even point but remember reading a Shaw & Partners broker note that had the breakeven point (at net income level) somewhere between FY22-FY23. Cash flow breakeven should occur earlier given FZO collects cash upfront on SAAS transactions.
Anyway a reminder: "The speed at which a business's success is recognised is not that important as long as the company's intrinsic value is increasing at a satisfactory rate. in fact, delayed recognition can be an advantage: It may give us the chance to buy more of a good thing at a bargain price."
I'm focused on the direction of FZO's business growth - which IMO is trending very nicely.
- Forums
- ASX - By Stock
- Ann: Investor Update Presentation - March 2021
FZO is a 'long duration' play as it's still not profitable and...
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add QOR (ASX) to my watchlist
(20min delay)
|
|||||
Last
39.5¢ |
Change
0.025(6.76%) |
Mkt cap ! $470.6M |
Open | High | Low | Value | Volume |
36.0¢ | 39.5¢ | 34.5¢ | $1.249M | 3.423M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 67001 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.5¢ | 126783 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 27814 | 0.380 |
1 | 29451 | 0.375 |
1 | 60000 | 0.345 |
1 | 23941 | 0.335 |
1 | 127000 | 0.305 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 3100 | 1 |
0.380 | 23450 | 1 |
0.395 | 101783 | 2 |
0.400 | 97830 | 3 |
0.405 | 100000 | 1 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
QOR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online